Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001601830-23-000042
Filing Date
2023-06-09
Accepted
2023-06-09 07:25:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 cyclicaprospectussupplement.htm 424B5 695115
2 EX-FILING FEES exhibit107-cyclica.htm EX-FILING FEES 32805
3 image_1.jpg GRAPHIC 29242
4 image_2.jpg GRAPHIC 15523
  Complete submission text file 0001601830-23-000042.txt   787306
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264845 | Film No.: 231003868
SIC: 2836 Biological Products, (No Diagnostic Substances)